|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3066128 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14803287.3 |
| Europos patento paraiškos padavimo data | 2014-11-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/064153 |
| Data | 2014-11-05 |
| (87) | Numeris | WO 2015/069785 |
| Data | 2015-05-14 |
| (30) | Numeris | Data | Šalis |
| 201361900775 P | 2013-11-06 | US |
| (72) |
ANDRE, Pascale, FR
BLERY, Mathieu, FR
BONNAFOUS, Cecile, FR
GUPTA, Ashok, K., US
SALTER-CID, Luisa, M., US
ROBBINS, Michael Darron, US
|
| (73) |
Innate Pharma,
117, Avenue de Luminy, 13009 Marseille,
FR
Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US |
| (54) | COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA |
| COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA |